The primary aim of this study is to determine the effect of finasteride (a 5 alpha-reductase inhibitor) on the progression of androgen-dependent scalp hair loss. This was a randomized, double-blind, placebo-controlled multicenter study. Progress report and summary of findings: This was a drug sponsored trial that was completed. The drug received FDA approval for the treatment of male pattern baldness. Open label studies are continuing.
Showing the most recent 10 out of 370 publications